VTR Stock Analysis — Ventas, Inc.
Sector: Healthcare REIT
AI Verdict
Ventas trades at 103x next year's earnings with 54% expected EPS growth — that's paying a premium the numbers don't yet support, and the moat around senior housing won't protect against a multiple collapse if growth stalls.
Competitive Moat
Ventas owns and operates a diversified portfolio of senior housing and healthcare real estate, benefiting from long-term demographic tailwinds as the US population ages. Its scale and relationships with major healthcare operators create barriers to entry for smaller landlords.
Summary
Ventas is notable for its sharp 33.59% 1-year return as investors bet on a rebound in senior housing demand.
Where It Stands
The stock is up 33.59% in the past year, trades at 103.4x forward earnings versus a healthcare sector median of 22x, and its RSI of 72.5 signals overbought territory.
Key Metrics
- RSI: 72.5 — Overbought
- Trailing P/E: 159.7x
- Forward P/E: 103.4x
- PEG Ratio: 2.99
- Earnings Growth: +0.5%
- Revenue Growth: +0.2%
- Market Cap: $42.9B
- Dividend Yield: 0.02%
- 1-Year Return: 33.59%
- 52-Week High: $88.50
- 52-Week Low: $61.76
Analyst Consensus
21 Buy · 4 Hold · 0 Sell (25 analysts)
Bull Case
With analysts projecting 54.4% forward EPS growth, the market is betting on a sharp earnings recovery to justify the high multiple.
Bear Case
If the P/E ratio reverts from 103.4x to the sector median of 22x, the stock could lose nearly 80% of its value even if earnings meet expectations.
Catalyst to Watch
Quarterly earnings and occupancy updates — any disappointment in EPS growth or tenant performance could trigger a sharp pullback.